Most categories in chapter 19 have a 7 character requirement for each applicable code. Most categories in this chapter have three 7 character values (with the exception of fractures): A, initial encounter, D, subsequent encounter and S, sequela. Categories for traumatic fractures have additional 7 character values. While the patient may be seen by a new or different provider over the course of treatment for an injury, assignment of the 7 character is based on whether the patient is undergoing active treatment and not whether the provider is seeing the patient for the first time. For complication codes, active treatment refers to treatment for the condition described by the code, even though it may be related to an earlier precipitating problem. For example, code T84.50XA, Infection and inflammatory reaction due to unspecified internal joint prosthesis, initial encounter, is used when active treatment is provided for the infection, even though the condition relates to the prosthetic device, implant or graft that was placed at a previous encounter. 7 character “A”, initial encounter is used for each encounter where the patient is receiving active treatment for the condition. 7 character “D” subsequent encounter is used for encounters after the patient has completed active treatment of the condition and is receiving routine care for the condition during the healing or recovery phase. The aftercare Z codes should not be used for aftercare for conditions such as injuries or poisonings, where 7 characters are provided to identify subsequent care. For example, for aftercare of an injury, assign the acute injury code with the 7 character “D” (subsequent encounter). 7 character “S”, sequela, is for use for complications or conditions that arise as a direct result of a condition, such as scar formation after a burn. The scars are sequelae of the burn. When using 7 character “S”, it is necessary to use both the injury code that precipitated the sequela and the code for the sequela itself. The “S” is added only to the injury code, not the sequela code. The 7 character “S” identifies the injury responsible for the sequela. The specific type of sequela (e.g. scar) is sequenced first, followed by the injury code. See Section I.B.10. Sequelae, (Late Effects)
T79.A0
BookmarkCompartment syndrome, unspecified
Filed alongside this entry 777
under Syndrome
- 4H G11.5
- 5q minus NOS D46.C
- 22q13.3 deletion Q93.52
- 48,XXXX Q97.1
- 49,XXXXX Q97.1
- abnormal innervation H02.519
- abstinence, neonatal P96.1
- acid pulmonary aspiration, obstetric O74.0
- activated phosphoinositide 3-kinase delta syndrome [APDS] D81.82
- acute abdominal R10.0
- acute respiratory distress (adult) (child) J80
- Adair-Dighton Q78.0
- Adams-Stokes (-Morgagni) I45.9
- adiposogenital E23.6
- adrenogenital E25.9
- afferent loop NEC K91.89
- Aicardi-Goutières E79.81
- Alagille (-Watson) Q44.71
- Alder's D72.0
- Aldrich (-Wiskott) D82.0
- alien hand R41.4
- Alpha-gal Z91.014
- Alport Q87.81
- alveolar hypoventilation E66.2
- alveolocapillary block J84.10
- amyostatic (Wilson's disease) E83.01
- androgen insensitivity E34.50
- androgen resistance E34.50
- Angelman Q93.51
- ankyloglossia superior Q38.1
- antibody deficiency D80.9
- anticardiolipin (-antibody) D68.61
- antidepressant discontinuation T43.205
- antiphospholipid (-antibody) D68.61
- aortomesenteric duodenum occlusion K31.5
- apical ballooning (transient left ventricular) I51.81
- arcuate ligament I77.4
- argentaffin, argintaffinoma E34.09
- Arrillaga-Ayerza I27.0
- arterial tortuosity Q87.82
- arteriovenous steal T82.898
- Asherman's N85.6
- ataxia-telangiectasia G11.3
- auriculotemporal G50.8
- autoerythrocyte sensitization (Gardner-Diamond) D69.2
- autoimmune polyglandular E31.0
- autoimmune lymphoproliferative [ALPS] D89.82
- autoinflammatory M04.9
- Avellis' G46.8
- Axenfeld-Rieger Q13.81
- Ayerza (-Arrillaga) I27.0
- Babinski-Nageotte G83.89
- Bakwin-Krida Q78.5
- Bardet-Biedl Q87.83
- bare lymphocyte D81.6
- Barré-Guillain G61.0
- Barré-Liéou M53.0
- Barsony-Polgar K22.4
- Barsony-Teschendorf K22.4
- Barth E78.71
- Bartter's E26.81
- basal cell nevus Q87.89
- Basedow's E05.00
- basilar artery G45.0
- Batten-Steinert G71.11
- Beals Q87.40
- Beau's I51.5
- Beck's I65.8
- Benedikt's G46.3
- Béquez César (-Steinbrinck-Chédiak-Higashi) E70.330
- Berardinelli-Siep E88.12
- big spleen D73.1
- bilateral polycystic ovarian E28.2
- Birt-Hogg-Dube syndrome Q87.89
- Björck (-Thorsen) E34.09
- Blackfan-Diamond D61.01
- Blau M04.8
- blind loop K90.2
- blue sclera Q78.0
- blue toe I75.02
- Boder-Sedgewick G11.3
- Boerhaave's K22.3
- Borjeson Forssman Lehmann Q89.89
- Bouillaud's I01.9
- Bourneville (-Pringle) Q85.1
- Bouveret (-Hoffman) I47.9
- brachial plexus G54.0
- bradycardia-tachycardia I49.5
- brain (nonpsychotic) F09
- brain stem stroke G46.3
- Brandt's (acrodermatitis enteropathica) E83.2
- BRCA1-cancer predisposition QA1.790
- BRCA2-cancer predisposition QA1.791
- broad ligament laceration N83.8
- Brock's J98.11
- bronchiolitis obliterans J44.81
- bronze baby P83.88
- Brown-Sequard G83.81
- Brugada I49.81
- bubbly lung P27.0
- Buchem's M85.2
- Budd-Chiari I82.0
- bulbar (progressive) G12.22
- Bürger-Grütz E78.3
- Burke's K86.89
- Burnett's (milk-alkali) E83.52
- burning feet E53.9
- Bywaters' T79.5
- Call-Fleming I67.841
- cannabinoid hyperemesis R11.16
- cannabis hyperemesis R11.16
- carbohydrate-deficient glycoprotein (CDGS) E77.8
- carcinogenic thrombophlebitis I82.1
- carcinoid E34.00
- cardiac asthma I50.1
- cardiacos negros I27.0
- cardiofaciocutaneous Q87.89
- cardiopulmonary-obesity E66.2
- cardiorespiratory distress (idiopathic) , newborn P22.0
- carpal tunnel G56.0
- Cassidy (-Scholte) E34.09
- cat cry Q93.4
- cat eye Q92.8
- cauda equina G83.4
- celiac K90.0
- central pain G89.0
- cervical (root) M53.1
- cervicobrachial (diffuse) M53.1
- cervicocranial M53.0
- cervicodorsal outlet G54.2
- cervicothoracic outlet G54.0
- Céstan (-Raymond) I65.8
- Charcot's (angina cruris) (intermittent claudication) I73.9
- Charcot-Weiss-Baker G90.09
- CHARGE Q89.89
- Chédiak-Higashi (-Steinbrinck) E70.330
- chest wall R07.1
- Chiari's (hepatic vein thrombosis) I82.0
- Chilaiditi's Q43.3
- chondrocostal junction M94.0
- chondroectodermal dysplasia Q77.6
- chromosome 4 short arm deletion Q93.3
- chromosome 5 short arm deletion Q93.4
- Churg-Strauss M30.1
- Clarke-Hadfield K86.89
- Clerambault's automatism G93.89
- clinically isolated G37.9
- Clouston's (hidrotic ectodermal dysplasia) Q82.4
- clumsiness, clumsy child F82
- cluster headache G44.009
- Coffin-Lowry Q89.89
- cold injury (newborn) P80.0
- combined immunity deficiency D81.9
- compartment (deep) (posterior) (traumatic) T79.A0
- compression T79.5
- concussion F07.81
- congestion-fibrosis (pelvic) , female N94.89
- congestive dysmenorrhea N94.6
- Conn's E26.01
- connective tissue M35.9
- conus medullaris G95.81
- Costen's (complex) M26.69
- costochondral junction M94.0
- costoclavicular G54.0
- costovertebral E22.0
- craniovertebral M53.0
- cri-du-chat Q93.4
- crib death R99
- croup J05.0
- crush T79.5
- CTNNB1 Q87.88
- Curschmann (-Batten) (-Steinert) G71.11
- Cushing's E24.9
- cryopyrin-associated periodic M04.2
- cryptophthalmos Q87.0
- cystic duct stump K91.5
- cytokine release D89.839
- Dana-Putnam D51.0
- Danbolt (-Cross) (acrodermatitis enteropathica) E83.2
- Dandy-Walker Q03.1
- Danlos' Q79.60
- Degos' I77.89
- Déjérine-Roussy G89.0
- delayed sleep phase G47.21
- demyelinating G37.9
- depersonalization (-derealization) F48.1
- De Quervain E34.51
- de Toni-Fanconi (-Debré) E72.09
- de Vivo syndrome E74.810
- diabetes mellitus in newborn infant P70.2
- dialysis associated steal T82.898
- Diamond-Blackfan D61.01
- Diamond-Gardener D69.2
- DIC (diffuse or disseminated intravascular coagulopathy) D65
- di George's D82.1
- Dighton's Q78.0
- disequilibrium E87.8
- Döhle body-panmyelopathic D72.0
- dorsolateral medullary G46.4
- double athetosis G80.3
- Down Q90.9
- Dravet (intractable) G40.834
- Dresbach's (elliptocytosis) D58.1
- DRESS (drug rash with eosinophilia and systemic symptoms) D72.12
- Dressler's (postmyocardial infarction) I24.1
- drug rash with eosinophilia and systemic symptoms (DRESS) D72.12
- drug withdrawal, infant of dependent mother P96.1
- dry eye H04.12
- dumping (postgastrectomy) K91.1
- Dupré's (meningism) R29.1
- dysmetabolic X E88.810
- dyspraxia, developmental F82
- Eagle-Barrett Q79.4
- Ebstein's Q22.5
- ectopic ACTH E24.3
- eczema-thrombocytopenia D82.0
- Eddowes' Q78.0
- effort (psychogenic) F45.8
- Eisenmenger's I27.83
- Ehlers-Danlos Q79.60
- Ekman's Q78.0
- electric feet E53.8
- Ellis-van Creveld Q77.6
- empty nest Z60.0
- endocrine-hypertensive E27.0
- eosinophilia-myalgia M35.89
- Erdheim-Chester (ECD) E88.89
- Erdheim's E22.0
- erythrocyte fragmentation D59.4
- Evans D69.41
- exhaustion F48.8
- extrapyramidal G25.9
- eyelid-malar-mandible Q87.0
- Faber's D50.9
- facet M47.89
- facet joint M47.819
- facial pain, paroxysmal G50.0
- Fallot's Q21.3
- familial cold autoinflammatory M04.2
- familial eczema-thrombocytopenia (Wiskott-Aldrich) D82.0
- Fanconi (-de Toni) (-Debré) E72.09
- faulty bowel habit K59.39
- Feil-Klippel (brevicollis) Q76.1
- fertile eunuch E23.0
- Fiedler's I40.1
- first arch Q87.0
- fish odor E72.89
- Fisher's G61.0
- Fitz's K85.80
- Flajani (-Basedow) E05.00
- flush E34.09
- Foix-Alajouanine G95.19
- Fong's Q87.2
- food protein-induced enterocolitis (FPIES) K52.21
- foramen magnum G93.5
- Foster-Kennedy H47.14
- Foville's (peduncular) G46.3
- FOXG1 QA0.0151
- fragile X Q99.2
- Franceschetti Q75.4
- Friderichsen-Waterhouse A39.1
- Froin's G95.89
- frontal lobe F07.0
- Fukuhara E88.49
- Gaisböck's D75.1
- ganglion (basal ganglia brain) G25.9
- Gardner-Diamond D69.2
- gastrojejunal loop obstruction K91.89
- Gee-Herter-Heubner K90.0
- Gelineau's G47.419
- genito-anorectal A55
- Gerstmann-Sträussler-Scheinker (GSS) A81.82
- Gianotti-Crosti L44.4
- giant platelet (Bernard-Soulier) D69.19
- Gilles de la Tourette's F95.2
- Glass Q87.89
- Gleich's D72.118
- goiter-deafness E07.1
- Goldberg Q89.89
- Goldberg-Maxwell E34.51
- Good's D83.8
- Gopalan's (burning feet) E53.8
- Gorlin's Q87.89
- Gougerot-Blum L81.7
- Gouley's I31.1
- Gower's R55
- gray or grey (newborn) P93.0
- Gubler-Millard G46.3
- Guillain-Barré (-Strohl) G61.0
- Gulf war T75.830
- gustatory sweating G50.8
- Hadfield-Clarke K86.89
- Hamman's J98.19
- hand-foot L27.1
- hand-shoulder G90.89
- hantavirus (cardio)-pulmonary (HPS) (HCPS) B33.4
- Hao-Fountain (HAFOUS) Q87.87
- happy puppet Q93.51
- Harada's H30.81
- Hayem-Faber D50.9
- headache NEC G44.89
- Heberden's I20.89
- Hedinger's E34.01
- Hegglin's D72.0
- HELLP (hemolysis, elevated liver enzymes and low platelet count) O14.2
- hemolytic-uremic D59.30
- hemophagocytic, infection-associated D76.2
- Henoch-Schönlein D69.0
- hepatic flexure K59.89
- hepatopulmonary K76.81
- hepatorenal K76.7
- hepatourologic K76.7
- hereditary alpha tryptasemia D89.44
- Herter (-Gee) (nontropical sprue) K90.0
- Heubner-Herter K90.0
- Heyd's K76.7
- Hilger's G90.09
- histiocytic D76.3
- histiocytosis NEC D76.3
- HIV infection, acute B20
- Hoffmann-Werdnig G12.0
- Hollander-Simons E88.19
- Hoppe-Goldflam G70.00
- Horner's G90.2
- hungry bone E83.81
- hunterian glossitis D51.0
- Hunt's (herpetic geniculate ganglionitis) (neuralgia) B02.21
- Hutchinson's triad A50.53
- hyperabduction G54.0
- hyperammonemia-hyperornithinemia-homocitrullinemia E72.4
- hypereosinophilic (HES) D72.119
- hyperimmunoglobulin D M04.1
- hyperimmunoglobulin E (IgE) D82.4
- hyperkalemic E87.5
- hypermobility M35.7
- hypernatremia E87.0
- hyperosmolarity (see also, Diabetes, by type, with hyperosmolarity) E87.0
- hyperperfusion G97.82
- hypersplenic D73.1
- hypertransfusion, newborn P61.1
- hyperventilation F45.8
- hypoglycemic (familial) (neonatal) E16.2
- hypokalemic E87.6
- hyponatremic E87.1
- hypopituitarism E23.0
- hypoplastic left-heart Q23.4
- hypopotassemia E87.6
- hyposmolality E87.1
- hypotension, maternal O26.5
- hypothenar hammer I73.89
- hypoventilation, obesity (OHS) E66.2
- ICF (intravascular coagulation-fibrinolysis) D65
- iliotibial band M76.3
- immobility, immobilization (paraplegic) M62.3
- immune effector cell-associated neurotoxicity (ICANS) G92.00
- immune reconstitution D89.3
- immune reconstitution inflammatory [IRIS] D89.3
- immunity deficiency, combined D81.9
- impending coronary I20.0
- impingement, shoulder M75.4
- inappropriate secretion of antidiuretic hormone E22.2
- infantilism (pituitary) E23.0
- inferior vena cava I87.1
- inherited neoplasm predisposition syndrome of multiple systems, specified NEC QA1.798
- inspissated bile (newborn) P59.1
- institutional (childhood) F94.2
- insufficient sleep F51.12
- intermediate coronary (artery) I20.0
- intravascular coagulation-fibrinolysis (ICF) D65
- iodine-deficiency, congenital E00.9
- IRDS (idiopathic respiratory distress, newborn) P22.0
- IVC (intravascular coagulopathy) D65
- Ivemark's Q89.01
- Jackson's G83.89
- jaw-winking Q07.8
- Jervell-Lange-Nielsen I45.81
- jet lag G47.25
- Job's D71.8
- Joseph-Diamond-Blackfan D61.01
- jugular foramen G52.7
- Kabuki (type 1, due to KMT2D mutation) (type 2, due to KDM6A mutation) Q89.81
- Kanner's (autism) F84.0
- Kartagener's Q89.3
- Kelly's D50.1
- Kleefstra Q87.86
- Klein (e) -Levine G47.13
- Klippel-Feil (brevicollis) Q76.1
- König's K59.89
- Korsakoff (-Wernicke) (nonalcoholic) F04
- Kostmann's D70.0
- Krabbe's congenital muscle hypoplasia Q79.8
- lacunar NEC G46.7
- Lambert-Eaton G70.80
- Larsen's Q74.8
- Lassueur Graham-Little Piccardi L66.19
- Launois' E22.0
- Laurence-Moon Q87.84
- Lawrence E88.12
- Lemierre I80.8
- Lennox-Gastaut G40.812
- lenticular, progressive E83.01
- Leopold-Levi's E05.90
- Lev's I44.2
- Li-Fraumeni QA1.792
- Lichtheim's D51.0
- Lightwood's N25.89
- Lignac (de Toni) (-Fanconi) (-Debré) E72.09
- Likoff's I20.89
- limbic epilepsy personality F07.0
- liver-kidney K76.7
- lobotomy F07.0
- Loeys-Dietz Q87.A
- Löffler's J82.89
- long arm 18 or 21 deletion Q93.89
- long QT I45.81
- Louis-Barré G11.3
- lower radicular, newborn (birth injury) P14.8
- Luetscher's (dehydration) E86.0
- Lupus anticoagulant D68.62
- Lutembacher's Q21.19
- Lynch (due to EPCAM) (due to MLH1) (due to MSH2) (due to MSH6) (due to PMS2) QA1.71
- macrophage activation D76.1
- magnesium-deficiency R29.0
- Majeed M04.8
- Mal de Debarquement R42
- malabsorption K90.9
- Mallory-Weiss K22.6
- mandibulofacial dysostosis Q75.4
- maple-syrup-urine E71.0
- Marable's I77.4
- Marfan Q87.40
- Marie's (acromegaly) E22.0
- May (-Hegglin) D72.0
- McArdle (-Schmidt) (-Pearson) E74.04
- McQuarrie's E16.2
- meconium plug (newborn) P76.0
- MED13L (mediator complex subunit 13L) Q87.85
- median arcuate ligament I77.4
- mediator complex subunit 13L (MED13L) Q87.85
- Meekeren-Ehlers-Danlos Q79.6
- megavitamin-B6 E67.2
- Meige G24.4
- MELAS E88.41
- Mendelson's O74.0
- MERRF (myoclonic epilepsy associated with ragged-red fibers) E88.42
- metabolic E88.810
- metastatic carcinoid E34.00
- micrognathia-glossoptosis Q87.0
- midbrain NEC G93.89
- middle lobe (lung) J98.19
- middle radicular G54.0
- migraine G43.909
- Mikulicz' K11.8
- milk-alkali E83.52
- Millard-Gubler G46.3
- Miller-Dieker Q93.88
- Miller-Fisher G61.0
- Minkowski-Chauffard D58.0
- Mirizzi's K83.1
- MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy) E88.49
- monofixation H50.42
- Morel-Moore M85.2
- Morel-Morgagni M85.2
- Morgagni (-Morel) (-Stewart) M85.2
- Morgagni-Adams-Stokes I45.9
- Muckle-Wells M04.2
- mucocutaneous lymph node (acute febrile) (MCLS) M30.3
- multisystem inflammatory (in adults) (in children) M35.81
- Mounier-Kuhn Q32.4
- myasthenic G70.9
- myelodysplastic D46.9
- myeloid hypereosinophilic D72.118
- myelopathic pain G89.0
- myeloproliferative (chronic) D47.1
- myofascial pain M79.18
- Naffziger's G54.0
- nail patella Q87.2
- NARP (Neuropathy, Ataxia and Retinitis pigmentosa) E88.49
- neonatal abstinence P96.1
- nephrotic (congenital) N04.9
- neurologic neglect R41.4
- Nezelof's D81.4
- Niikawa-Kuroki Q89.81
- Nonne-Milroy-Meige Q82.0
- Nothnagel's vasomotor acroparesthesia I73.89
- obesity hypoventilation (OHS) E66.2
- oculomotor H51.9
- Ogilvie K59.81
- Oliver-McFarlane Q87.89
- oral allergy T78.19
- oral-facial-digital Q87.0
- Ormond's N13.5
- oro-facial-digital Q87.0
- os trigonum Q68.8
- Osler-Weber-Rendu I78.0
- osteoporosis-osteomalacia M83.8
- Osterreicher-Turner Q87.2
- oto-palatal-digital Q87.0
- outlet (thoracic) G54.0
- Owren's D68.2
- Paget-Schroetter I82.890
- paralytic G83.9
- Parinaud's H51.0
- paroxysmal facial pain G50.0
- Parry's E05.00
- Parsonage (-Aldren) -Turner G54.5
- patella clunk M25.86
- Paterson (-Brown) (-Kelly) D50.1
- pectoral girdle I77.89
- pectoralis minor I77.89
- pediatric acute-onset neuropsychiatric (PANS) D89.89
- pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) D89.89
- pediatric inflammatory multisystem M35.81
- Pelger-Huet D72.0
- pellagra-cerebellar ataxia-renal aminoaciduria E72.02
- pellagroid E52
- pelvic congestion-fibrosis, female N94.89
- penta X Q97.1
- perabduction I77.89
- periodic fever M04.1
- periodic fever, aphthous stomatitis, pharyngitis, and adenopathy [PFAPA] M04.8
- periurethral fibrosis N13.5
- Peutz-Jeghers Q85.89
- phantom limb (without pain) G54.7
- pharyngeal pouch D82.1
- Phelan-McDermid Q93.52
- Pickwickian E66.2
- PIE (pulmonary infiltration with eosinophilia) J82.89
- pigmentary pallidal degeneration (progressive) G23.0
- pineal E34.8
- pituitary E22.0
- plantar fascia M72.2
- plateau iris (post-iridectomy) (postprocedural) H21.82
- Plummer-Vinson D50.1
- pluricarential of infancy E40
- plurideficiency E40
- pluriglandular (compensatory) E31.8
- pneumatic hammer T75.21
- polyangiitis overlap M30.8
- polycarential of infancy E40
- polyglandular E31.8
- polysplenia Q89.09
- pontine NEC G93.89
- postbacterial fatigue G93.39
- postcardiotomy I97.0
- postcholecystectomy K91.5
- postcommissurotomy I97.0
- postconcussional F07.81
- postcontusional F07.81
- post-COVID (-19) U09.9
- postencephalitic F07.89
- post endometrial ablation N99.85
- post-polypectomy coagulation K91.89
- postgastrectomy (dumping) K91.1
- postgastric surgery K91.1
- postinfarction I24.1
- postinfectious fatigue G93.39
- postlaminectomy NEC M96.1
- postleukotomy F07.0
- postmastectomy lymphedema I97.2
- postmyocardial infarction I24.1
- postoperative NEC T81.9
- postpartum panhypopituitary (Sheehan) E23.0
- postpolio (myelitic) G14
- postthrombotic I87.009
- postvagotomy K91.1
- postvalvulotomy I97.0
- postviral NEC G93.31
- Potain's K31.0
- potassium intoxication E87.5
- Prader-Willi Q87.11
- Prader-Willi-like Q87.19
- precerebral artery (multiple) (bilateral) G45.2
- preinfarction I20.0
- preleukemic D46.9
- premature senility E34.8
- premenstrual dysphoric F32.81
- premenstrual tension N94.3
- Prinzmetal-Massumi R07.1
- prune belly Q79.4
- pseudoparalytica G70.00
- pseudo -Turner's Q87.19
- psycho-organic (nonpsychotic severity) F07.9
- PTEN (hamartoma) tumor Q85.81
- Putnam-Dana D51.0
- pyogenic arthritis, pyoderma gangrenosum, and acne [PAPA] M04.8
- pyramidopallidonigral G20.C
- QT interval prolongation I45.81
- rapid time-zone change G47.25
- Rasmussen G04.81
- Raymond (-Céstan) I65.8
- Raynaud's I73.00
- RDS (respiratory distress syndrome, newborn) P22.0
- reactive airways dysfunction J68.3
- Refsum's G60.1
- Reifenstein E34.52
- Rendu-Osler-Weber I78.0
- residual ovary N99.83
- resistant ovary E28.39
- restless legs G25.81
- restrictive allograft J4A.0
- retinoblastoma (familial) C69.2
- retroperitoneal fibrosis K68.2
- retroviral seroconversion (acute) Z21
- Reye's G93.7
- Ridley's I50.1
- Romano-Ward (prolonged QT interval) I45.81
- rotator cuff, shoulder M75.10
- rubella (congenital) P35.0
- Ruvalcaba-Myhre-Smith E71.440
- Rytand-Lipsitch I44.2
- salt-losing N28.89
- SATB2-associated Q87.89
- Scaglietti-Dagnini E22.0
- scalenus anticus (anterior) G54.0
- scapuloperoneal G71.09
- schizophrenic, of childhood NEC F20.9
- Schnitzler D47.2
- Scholte's E34.09
- Schroeder's E27.0
- Schüller-Christian C96.5
- Schwachman (-Diamond) D61.02
- Schwartz (-Jampel) G71.13
- Schwartz-Bartter E22.2
- scimitar Q26.8
- sclerocystic ovary E28.2
- Seitelberger's G31.89
- septicemic adrenal hemorrhage A39.1
- seroconversion, retroviral (acute) Z21
- serotonin G90.81
- serous meningitis G93.2
- severe acute respiratory (SARS) J12.81
- shaken infant T74.4
- shock (traumatic) T79.4
- shock-lung J80
- Shwachman (-Diamond) D61.02
- sick-euthyroid E07.81
- sideropenic D50.1
- Siemens' ectodermal dysplasia Q82.4
- Silfversköld's Q78.9
- Simons' E88.11
- sinus tarsi M25.57
- sinusitis-bronchiectasis-situs inversus Q89.3
- Sipple's E31.22
- sirenomelia Q87.2
- Sjögren M35.00
- Slocumb's E27.0
- slow flow, coronary I20.89
- Sluder's G44.89
- Smith-Magenis Q93.88
- Sneddon-Wilkinson L13.1
- Snyder-Robinson Q87.89
- Soto's Q87.3
- South African cardiomyopathy I42.89
- Spen's I45.9
- Spurway's Q78.0
- staphylococcal scalded skin L00
- Stein-Leventhal E28.2
- Stein's E28.2
- Stevens-Johnson syndrome L51.1
- Stewart-Morel M85.2
- Stickler Q89.89
- stiff baby Q89.89
- stiff man G25.82
- Stokes (-Adams) I45.9
- stone heart I50.1
- straight back, congenital Q76.49
- Sturge-Weber (-Dimitri) Q85.89
- subclavian steal G45.8
- subcoracoid-pectoralis minor G54.0
- subcostal nerve compression I77.89
- subphrenic interposition Q43.3
- suprarenal cortical E27.0
- supraspinatus M75.10
- Susac G93.49
- swallowed blood P78.2
- sweat retention L74.0
- Swyer Q99.1
- Symond's G93.2
- systemic inflammatory response (SIRS), of non-infectious origin (without organ dysfunction) R65.10
- tachycardia-bradycardia I49.5
- takotsubo I51.81
- TAR (thrombocytopenia with absent radius) Q87.2
- tarsal tunnel G57.5
- teething K00.7
- tegmental G93.89
- telangiectasic-pigmentation-cataract Q82.8
- temporomandibular joint-pain-dysfunction M26.62
- Terry's H44.2
- testicular feminization E34.51
- thalamic pain (hyperesthetic) G89.0
- thoracic outlet (compression) G54.0
- Thorson-Björck E34.09
- thrombocytopenia with absent radius (TAR) Q87.2
- thrombosis with thrombocytopenia D75.84
- thyroid-adrenocortical insufficiency E31.0
- Tietze's M94.0
- time-zone (rapid) G47.25
- Toni-Fanconi E72.09
- Touraine's Q79.8
- toxic shock A48.3
- transient left ventricular apical ballooning I51.81
- traumatic vasospastic T75.22
- Treacher Collins Q75.4
- triple X, female Q97.0
- trisomy Q92.9
- tropical wet feet T69.02
- Trousseau's I82.1
- tumor lysis (following antineoplastic chemotherapy) (spontaneous) NEC E88.3
- tumor necrosis factor receptor associated periodic (TRAPS) M04.1
- upward gaze H51.8
- uremia, chronic N18.9
- urethral N34.3
- urohepatic K76.7
- usher Q99.819
- vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic (VEXAS) M04.3
- vago-hypoglossal G52.7
- vanishing twin of one fetus or more O31.4
- vascular NEC in cerebrovascular disease G46.8
- vasoconstriction, reversible cerebrovascular I67.841
- vasomotor I73.9
- vasospastic (traumatic) T75.22
- vasovagal R55
- van Buchem's M85.2
- van der Hoeve's Q78.0
- VATER Q87.2
- velo-cardio-facial Q93.81
- vena cava (inferior) (superior) (obstruction) I87.1
- vertebro-basilar artery G45.0
- vertebrogenic (pain) M54.89
- VEXAS (vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) M04.3
- Vinson-Plummer D50.1
- virus B34.9
- visceral larva migrans B83.0
- visual disorientation H53.8
- vitamin B6 deficiency E53.1
- vitreal corneal H59.01
- vitreous (touch) H59.01
- Vogt-Koyanagi H20.82
- Volkmann's T79.6
- von Hippel-Lindau Q85.83
- von Schroetter's I82.890
- Waldenström-Kjellberg D50.1
- Wallenberg's G46.3
- wasting (syndrome) due to underlying condition E88.A
- water retention E87.79
- Waterhouse (-Friderichsen) A39.1
- Weber-Gubler G46.3
- Weber-Leyden G46.3
- Weber's G46.3
- Wegener's M31.30
- Weingarten's (tropical eosinophilia) J82.89
- Weiss-Baker G90.09
- Werdnig-Hoffman G12.0
- Wermer's E31.21
- Werner's E34.8
- Wernicke-Korsakoff (nonalcoholic) F04
- Westphal-Strümpell E83.01
- whiplash S13.4
- whistling face Q87.0
- Wilkie's K55.1
- Wilkinson-Sneddon L13.1
- Williams Q93.82
- Wilson's (hepatolenticular degeneration) E83.01
- Wiskott-Aldrich D82.0
- Woakes' (ethmoiditis) J33.1
- Wright's (hyperabduction) G54.0
- X I20.9
- XXXX Q97.1
- XXXXX Q97.1
- XXXXY Q98.1
- XXY Q98.0
- Yao M04.8
- yellow nail L60.5
- Zahorsky's B08.5
- Zellweger syndrome E71.510
- Zellweger-like syndrome E71.541
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions9never code together
7th character3
Instructional notes4
- Compartment syndrome NOS
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
- code to identify any retained foreign body, if applicable (Z18.-)Z18.-
Official Guidelines24
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
When coding injuries, assign separate codes for each injury unless a combination code is provided, in which case the combination code is assigned. Codes from category T07, Unspecified multiple injuries should not be assigned in the inpatient setting unless information for a more specific code is not available. Traumatic injury codes (S00- T14.9) are not to be used for normal, healing surgical wounds or to identify complications of surgical wounds. The code for the most serious injury, as determined by the provider and the focus of treatment, is sequenced first.
Superficial injuries such as abrasions or contusions are not coded when associated with more severe injuries of the same site.
When a primary injury results in minor damage to peripheral nerves or blood vessels, the primary injury is sequenced first with additional code(s) for injuries to nerves and spinal cord (such as category S04), and/or injury to blood vessels (such as category S15). When the primary injury is to the blood vessels or nerves, that injury should be sequenced first.
Injury codes from Chapter 19 should not be assigned for injuries that occur during, or as a result of, a medical intervention. Assign the appropriate complication code(s).
The principles of multiple coding of injuries should be followed in coding fractures. Fractures of specified sites are coded individually by site in accordance with both the provisions within categories S02, S12, S22, S32, S42, S49, S52, S59, S62, S72, S79, S82, S89, S92 and the level of detail furnished by medical record content. A fracture not indicated as open or closed should be coded to closed. A fracture not indicated whether displaced or not displaced should be coded to displaced. More specific guidelines are as follows:
Traumatic fractures are coded using the appropriate 7 character for initial encounter (A, B, C) for each encounter where the patient is receiving active treatment for the fracture. The appropriate 7 character for initial encounter should also be assigned for a patient who delayed seeking treatment for the fracture or nonunion. Fractures are coded using the appropriate 7 character for subsequent care for encounters after the patient has completed active treatment of the fracture and is receiving routine care for the fracture during the healing or recovery phase. Care for complications of surgical treatment for fracture repairs during the healing or recovery phase should be coded with the appropriate complication codes. Care of complications of fractures, such as malunion and nonunion, should be reported with the appropriate 7 character for subsequent care with nonunion (K, M, N,) or subsequent care with malunion (P, Q, R). Malunion/nonunion: The appropriate 7 character for initial encounter should also be assigned for a patient who delayed seeking treatment for the fracture or nonunion. The open fracture designations in the assignment of the 7th character for fractures of the forearm, femur and lower leg, including ankle are based on the Gustilo open fracture classification. When the Gustilo classification type is not specified for an open fracture, the 7th character for open fracture type I or II should be assigned (B, E, H, M, Q). A code from category M80, not a traumatic fracture code, should be used for any patient with known osteoporosis who suffers a fracture, even if the patient had a minor fall or trauma, if that fall or trauma would not usually break a normal, healthy bone. See Section I.C.13. Osteoporosis. The aftercare Z codes should not be used for aftercare for traumatic fractures. For aftercare of a traumatic fracture, assign the acute fracture code with the appropriate 7 character.
Multiple fractures are sequenced in accordance with the severity of the fracture.
For physeal fractures, assign only the code identifying the type of physeal fracture. Do not assign a separate code to identify the specific bone that is fractured.
The ICD-10-CM makes a distinction between burns and corrosions. The burn codes are for thermal burns, except sunburns, that come from a heat source, such as a fire or hot appliance. The burn codes are also for burns resulting from electricity and radiation. Corrosions are burns due to chemicals. The guidelines are the same for burns and corrosions. Current burns (T20-T25) are classified by depth, extent and by agent (X code). Burns are classified by depth as first degree (erythema), second degree (blistering), and third degree (full-thickness involvement). Burns of the eye and internal organs (T26-T28) are classified by site, but not by degree.
Sequence first the code that reflects the highest degree of burn when more than one burn is present. a. When the reason for the admission or encounter is for treatment of external multiple burns, sequence first the code that reflects the burn of the highest degree. b. When a patient has both internal and external burns, the circumstances of admission govern the selection of the principal diagnosis or first-listed diagnosis. c. When a patient is admitted for burn injuries and other related conditions such as smoke inhalation and/or respiratory failure, the circumstances of admission govern the selection of the principal or first-listed diagnosis.
Classify burns of the same anatomic site and on the same side but of different degrees to the subcategory identifying the highest degree recorded in the diagnosis (e.g., for second and third degree burns of right thigh, assign only code T24.311-).
Non-healing burns are coded as acute burns. Necrosis of burned skin should be coded as a non-healed burn.
For any documented infected burn site, use an additional code for the infection.
When coding burns, assign separate codes for each burn site. Category T30, Burn and corrosion, body region unspecified is extremely vague and should rarely be used. Codes for burns of "multiple sites" should only be assigned when the medical record documentation does not specify the individual sites.
surface involved Assign codes from category T31, Burns classified according to extent of body surface involved, or T32, Corrosions classified according to extent of body surface involved, for acute burns or corrosions when the site of the burn or corrosion is not specified or when there is a need for additional data. It is advisable to use category T31 as additional coding when needed to provide data for evaluating burn mortality, such as that needed by burn units. It is also advisable to use category T31 as an additional code for reporting purposes when there is mention of a third- degree burn involving 20 percent or more of the body surface. Codes from categories T31 and T32 should not be used for sequelae of burns or corrosions. Categories T31 and T32 are based on the classic “rule of nines” in estimating body surface involved: head and neck are assigned nine percent, each arm nine percent, each leg 18 percent, the anterior trunk 18 percent, posterior trunk 18 percent, and genitalia one percent. Providers may change these percentage assignments where necessary to accommodate infants and children who have proportionately larger heads than adults, and patients who have large buttocks, thighs, or abdomen that involve burns.
Encounters for the treatment of the late effects of burns or corrosions (i.e., scars or joint contractures) should be coded with a burn or corrosion code with the 7 character “S” for sequela.
When appropriate, both a code for a current burn or corrosion with 7 character “A” or “D” and a burn or corrosion code with 7 character “S” may be assigned on the same record (when both a current burn and sequelae of an old burn exist). Burns and corrosions do not heal at the same rate and a current healing wound may still exist with sequela of a healed burn or corrosion. See Section I.B.10. Sequela (Late Effects)
An external cause code should be used with burns and corrosions to identify the source and intent of the burn, as well as the place where it occurred.
Codes in categories T36-T65 are combination codes that include the substance that was taken as well as the intent. No additional external cause code is required for poisonings, toxic effects, adverse effects and underdosing codes.
Do not code directly from the Table of Drugs and Chemicals. Always refer back to the Tabular List.
Use as many codes as necessary to describe completely all drugs, medicinal or biological substances.
If the same code would describe the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, assign the code only once.
If two or more drugs, medicinal or biological substances are taken, code each individually unless a combination code is listed in the Table of Drugs and Chemicals. If multiple unspecified drugs, medicinal or biological substances were taken, assign the appropriate code from subcategory T50.91, Poisoning by, adverse effect of and underdosing of multiple unspecified drugs, medicaments and biological substances.
Index entries leading here2
Alongside this code4same parent — T79.A
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.